Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1309 (LINC01309) is a human long non-coding RNA (lncRNA), formally assigned by the HUGO Gene Nomenclature Committee (HGNC)[1]. It does not code for protein and its precise biological function is currently unknown. Its alias is TCONS_l2_00007459 and it can be found under the official gene symbol LINC01309 in major genomic databases. Unlike well-characterized lncRNAs such as HOTAIR or GAS5, there is currently no peer-reviewed evidence linking LINC01309 to specific cellular functions, disease roles, or therapeutic intervention[1][3][5][7]. Therefore, LINC01309 should be classified as a non-coding RNA locus, not as a druggable target, receptor, or biomarker. If new functional or disease-association data emerges in the future, classifications should be updated accordingly. For now, its entry is strictly as a genomic locus encoding a long non-coding RNA with no established therapeutic relevance.
None. Because there are no drugs targeting LINC01309, no mechanisms of action can be described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1309 (LINC01309).